IDEAS home Printed from https://ideas.repec.org/a/nat/natcom/v15y2024i1d10.1038_s41467-024-51315-8.html
   My bibliography  Save this article

A real-world observation of patients with glioblastoma treated with a personalized peptide vaccine

Author

Listed:
  • Pauline Latzer

    (Zentrum für Humangenetik Tübingen)

  • Henning Zelba

    (Zentrum für Humangenetik Tübingen)

  • Florian Battke

    (CeGaT GmbH)

  • Annekathrin Reinhardt

    (Zentrum für Humangenetik Tübingen)

  • Borong Shao

    (Zentrum für Humangenetik Tübingen)

  • Oliver Bartsch

    (Zentrum für Humangenetik Tübingen)

  • Armin Rabsteyn

    (Zentrum für Humangenetik Tübingen)

  • Johannes Harter

    (CeGaT GmbH)

  • Martin Schulze

    (Zentrum für Humangenetik Tübingen)

  • Thomas Okech

    (MVZ Zentrum für ambulante Onkologie GmbH)

  • Alexander Golf

    (MVZ Zentrum für ambulante Onkologie GmbH)

  • Christina Kyzirakos-Feger

    (Zentrum für Humangenetik Tübingen)

  • Simone Kayser

    (Zentrum für Humangenetik Tübingen)

  • Natalia Pieper

    (Zentrum für Humangenetik Tübingen)

  • Magdalena Feldhahn

    (CeGaT GmbH)

  • Julian Wünsche

    (Zentrum für Humangenetik Tübingen
    MVZ Zentrum für ambulante Onkologie GmbH)

  • Christian Seitz

    (KiTZ, Hopp Children’s Cancer Center)

  • Dirk Hadaschik

    (CeCaVa GmbH)

  • Claus Garbe

    (University Hospital Tübingen)

  • Till-Karsten Hauser

    (Universitätsklinikum Tübingen)

  • Christian Fougère

    (Universitätsklinikum Tübingen)

  • Dirk Biskup

    (CeGaT GmbH)

  • Dawn Brooke

    (Provenance Precision Medicine Foundation)

  • David Parker

    (PHM)

  • Uwe M. Martens

    (Cancer Center Heilbronn-Franken, SLK Kliniken GmbH)

  • Gerald Illerhaus

    (Klinikum Stuttgart)

  • Deborah T. Blumenthal

    (Tel-Aviv University)

  • Ryan Merrell

    (Vanderbilt University Medical Center)

  • Luisa Sánchez Lorenzo

    (Clínica Universidad de Navarra)

  • Máté Hidvégi

    (Jewish Theological Seminary—University of Jewish Studies (OR-ZSE))

  • Paula Robles

    (University of Calgary
    Tom Baker Cancer Centre)

  • Sied Kebir

    (Universitätsklinikum Essen)

  • William W. Li

    (Angiogenesis Foundation)

  • Vincent W. Li

    (Angiogenesis Foundation
    Harvard Medical School Dermatology)

  • Matthew Williams

    (NHS London)

  • Alexandra M. Miller

    (NYU Langone Health’s Perlmutter Cancer Center)

  • Santosh Kesari

    (Providence Saint John’s Health Center)

  • Michael Castro

    (Cellworks Group Inc
    Personalized Cancer Medicine, PLLC)

  • Annick Desjardins

    (Duke University Medical Center)

  • David M. Ashley

    (Duke University Medical Center
    Duke University)

  • Henry S. Friedman

    (Duke University Medical Center)

  • Patrick Y. Wen

    (Harvard Medical School)

  • Elisabeth C. Neil

    (University of Minnesota Health)

  • Fabio M. Iwamoto

    (Columbia University Medical Center)

  • Bence Sipos

    (Molekularpathologie Baden-Württemberg GbR)

  • Karsten Geletneky

    (Klinikum Darmstadt GmbH)

  • Lars Zender

    (Internal Medicine VIII)

  • Martin Glas

    (Universitätsklinikum Essen Klinik für Neurologie)

  • David A. Reardon

    (Harvard Medical School)

  • Saskia Biskup

    (Zentrum für Humangenetik Tübingen
    CeGaT GmbH)

Abstract

Current treatment outcome of patients with glioblastoma (GBM) remains poor. Following standard therapy, recurrence is universal with limited survival. Tumors from 173 GBM patients are analysed for somatic mutations to generate a personalized peptide vaccine targeting tumor-specific neoantigens. All patients were treated within the scope of an individual healing attempt. Among all vaccinated patients, including 70 treated prior to progression (primary) and 103 treated after progression (recurrent), the median overall survival from first diagnosis is 31.9 months (95% CI: 25.0–36.5). Adverse events are infrequent and are predominantly grade 1 or 2. A vaccine-induced immune response to at least one of the vaccinated peptides is detected in blood samples of 87 of 97 (90%) monitored patients. Vaccine-specific T-cell responses are durable in most patients. Significantly prolonged survival is observed for patients with multiple vaccine-induced T-cell responses (53 months) compared to those with no/low induced responses (27 months; P = 0.03). Altogether, our results highlight that the application of personalized neoantigen-targeting peptide vaccine is feasible and represents a promising potential treatment option for GBM patients.

Suggested Citation

  • Pauline Latzer & Henning Zelba & Florian Battke & Annekathrin Reinhardt & Borong Shao & Oliver Bartsch & Armin Rabsteyn & Johannes Harter & Martin Schulze & Thomas Okech & Alexander Golf & Christina K, 2024. "A real-world observation of patients with glioblastoma treated with a personalized peptide vaccine," Nature Communications, Nature, vol. 15(1), pages 1-9, December.
  • Handle: RePEc:nat:natcom:v:15:y:2024:i:1:d:10.1038_s41467-024-51315-8
    DOI: 10.1038/s41467-024-51315-8
    as

    Download full text from publisher

    File URL: https://www.nature.com/articles/s41467-024-51315-8
    File Function: Abstract
    Download Restriction: no

    File URL: https://libkey.io/10.1038/s41467-024-51315-8?utm_source=ideas
    LibKey link: if access is restricted and if your library uses this service, LibKey will redirect you to where you can use your library subscription to access this item
    ---><---

    References listed on IDEAS

    as
    1. Norbert Hilf & Sabrina Kuttruff-Coqui & Katrin Frenzel & Valesca Bukur & Stefan Stevanović & Cécile Gouttefangeas & Michael Platten & Ghazaleh Tabatabai & Valerie Dutoit & Sjoerd H. Burg & Per thor St, 2019. "Actively personalized vaccination trial for newly diagnosed glioblastoma," Nature, Nature, vol. 565(7738), pages 240-245, January.
    2. Marco Caliendo & Sabine Kopeinig, 2008. "Some Practical Guidance For The Implementation Of Propensity Score Matching," Journal of Economic Surveys, Wiley Blackwell, vol. 22(1), pages 31-72, February.
    3. Michael Platten & Lukas Bunse & Antje Wick & Theresa Bunse & Lucian Cornet & Inga Harting & Felix Sahm & Khwab Sanghvi & Chin Leng Tan & Isabel Poschke & Edward Green & Sune Justesen & Geoffrey A. Beh, 2021. "A vaccine targeting mutant IDH1 in newly diagnosed glioma," Nature, Nature, vol. 592(7854), pages 463-468, April.
    4. Derin B. Keskin & Annabelle J. Anandappa & Jing Sun & Itay Tirosh & Nathan D. Mathewson & Shuqiang Li & Giacomo Oliveira & Anita Giobbie-Hurder & Kristen Felt & Evisa Gjini & Sachet A. Shukla & Zhutin, 2019. "Neoantigen vaccine generates intratumoral T cell responses in phase Ib glioblastoma trial," Nature, Nature, vol. 565(7738), pages 234-239, January.
    5. Floris P. Barthel & Kevin C. Johnson & Frederick S. Varn & Anzhela D. Moskalik & Georgette Tanner & Emre Kocakavuk & Kevin J. Anderson & Olajide Abiola & Kenneth Aldape & Kristin D. Alfaro & Donat Alp, 2019. "Longitudinal molecular trajectories of diffuse glioma in adults," Nature, Nature, vol. 576(7785), pages 112-120, December.
    6. Norbert Hilf & Sabrina Kuttruff-Coqui & Katrin Frenzel & Valesca Bukur & Stefan Stevanović & Cecile Gouttefangeas & Michael Platten & Ghazaleh Tabatabai & Valerie Dutoit & Sjoerd H. Burg & Per thor St, 2019. "Publisher Correction: Actively personalized vaccination trial for newly diagnosed glioblastoma," Nature, Nature, vol. 566(7745), pages 13-13, February.
    7. Ho, Daniel E. & Imai, Kosuke & King, Gary & Stuart, Elizabeth A., 2007. "Matching as Nonparametric Preprocessing for Reducing Model Dependence in Parametric Causal Inference," Political Analysis, Cambridge University Press, vol. 15(3), pages 199-236, July.
    8. Ho, Daniel & Imai, Kosuke & King, Gary & Stuart, Elizabeth A., 2011. "MatchIt: Nonparametric Preprocessing for Parametric Causal Inference," Journal of Statistical Software, Foundation for Open Access Statistics, vol. 42(i08).
    Full references (including those not matched with items on IDEAS)

    Most related items

    These are the items that most often cite the same works as this one and are cited by the same works as this one.
    1. Phuong Nguyen-Hoang, 2012. "Fiscal effects of budget referendums: evidence from New York school districts," Public Choice, Springer, vol. 150(1), pages 77-95, January.
    2. K. Poehlmann & R. Helm & O. Mauroner & J. Auburger, 2021. "Corporate spin-offs’ success factors: management lessons from a comparative empirical analysis with research-based spin-offs," Review of Managerial Science, Springer, vol. 15(6), pages 1767-1796, August.
    3. Matilde Cappelletti & Leonardo M. Giuffrida, 2024. "Targeted Bidders in Government Tenders," CESifo Working Paper Series 11142, CESifo.
    4. Chervier, Colas & Le Velly, Gwenolé & Ezzine-de-Blas, Driss, 2019. "When the Implementation of Payments for Biodiversity Conservation Leads to Motivation Crowding-out: A Case Study From the Cardamoms Forests, Cambodia," Ecological Economics, Elsevier, vol. 156(C), pages 499-510.
    5. Akoh Fabien Yao & Maxime Sèbe & Laura Recuero Virto & Abdelhak Nassiri & Hervé Dumez, 2024. "The effect of LNG bunkering on port competitiveness using multilevel data analysis [L'effet du soutage par GNL sur la compétitivité des ports à l'aide de l'analyse de données à plusieurs niveaux]," Post-Print hal-04611804, HAL.
    6. Rigdon, Joseph & Berkowitz, Seth A. & Seligman, Hilary K. & Basu, Sanjay, 2017. "Re-evaluating associations between the Supplemental Nutrition Assistance Program participation and body mass index in the context of unmeasured confounders," Social Science & Medicine, Elsevier, vol. 192(C), pages 112-124.
    7. Finocchiaro Castro, Massimo & Guccio, Calogero & Rizzo, Ilde, 2023. "How "one-size-fits-all" public works contract does it better? An assessment of infrastructure provision in Italy," EconStor Preprints 270729, ZBW - Leibniz Information Centre for Economics.
    8. Stjepan Srhoj & Michael Lapinski & Janette Walde, 2019. "Size matters? Impact evaluation of business development grants on SME performance," Working Papers 2019-14, Faculty of Economics and Statistics, Universität Innsbruck.
    9. Robert J. R. Elliott & Liza Jabbour & Liyun Zhang, 2016. "Firm productivity and importing: Evidence from Chinese manufacturing firms," Canadian Journal of Economics/Revue canadienne d'économique, John Wiley & Sons, vol. 49(3), pages 1086-1124, August.
    10. Simone Bertoli & Francesca Marchetta, 2014. "Migration, Remittances and Poverty in Ecuador," Journal of Development Studies, Taylor & Francis Journals, vol. 50(8), pages 1067-1089, August.
    11. Backiny Yetna, Prosper Romuald, 2013. "Politiques publiques et pauvreté : trois études de cas d'évaluation des performances de ciblage et d'analyse d'impact," Economics Thesis from University Paris Dauphine, Paris Dauphine University, number 123456789/11794 edited by De Vreyer, Philippe.
    12. Gwenolé Le Velly & Céline Dutilly, 2016. "Evaluating Payments for Environmental Services: Methodological Challenges," PLOS ONE, Public Library of Science, vol. 11(2), pages 1-20, February.
    13. Patrick Christian Feihle & Jochen Lawrenz, 2017. "The Issuance of German SME Bonds and its Impact on Operating Performance," Schmalenbach Business Review, Springer;Schmalenbach-Gesellschaft, vol. 18(3), pages 227-259, August.
    14. Anna Haskins, 2013. "Mass Imprisonment and the Intergenerational Transmission of Disadvantage: Paternal Incarceration and Children’s Cognitive Skill Development," Working Papers wp13-15-ff, Princeton University, School of Public and International Affairs, Center for Research on Child Wellbeing..
    15. Ferentinos, Konstantinos & Gibberd, Alex & Guin, Benjamin, 2023. "Stranded houses? The price effect of a minimum energy efficiency standard," Energy Economics, Elsevier, vol. 120(C).
    16. Blackman, Allen & Naranjo, María Angélica & Robalino, Juan & Alpízar, Francisco & Rivera, Jorge, 2014. "Does Tourism Eco-Certification Pay? Costa Rica’s Blue Flag Program," World Development, Elsevier, vol. 58(C), pages 41-52.
    17. de Rassenfosse, Gaétan & Pellegrino, Gabriele & Raiteri, Emilio, 2024. "Do patents enable disclosure? Evidence from the invention secrecy act," International Journal of Industrial Organization, Elsevier, vol. 92(C).
    18. Gerhard Krug, 2017. "Augmenting propensity score equations to avoid misspecification bias – Evidence from a Monte Carlo simulation [Erweiterung der Propensity Score Gleichung zur Vermeidung von Fehlspezifikationen? Ein," AStA Wirtschafts- und Sozialstatistisches Archiv, Springer;Deutsche Statistische Gesellschaft - German Statistical Society, vol. 11(3), pages 205-231, December.
    19. Jones A.M & Rice N, 2009. "Econometric Evaluation of Health Policies," Health, Econometrics and Data Group (HEDG) Working Papers 09/09, HEDG, c/o Department of Economics, University of York.
    20. Deng, Yongheng & McMillen, Daniel P. & Sing, Tien Foo, 2012. "Private residential price indices in Singapore: A matching approach," Regional Science and Urban Economics, Elsevier, vol. 42(3), pages 485-494.

    More about this item

    Statistics

    Access and download statistics

    Corrections

    All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:nat:natcom:v:15:y:2024:i:1:d:10.1038_s41467-024-51315-8. See general information about how to correct material in RePEc.

    If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.

    If CitEc recognized a bibliographic reference but did not link an item in RePEc to it, you can help with this form .

    If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.

    For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Sonal Shukla or Springer Nature Abstracting and Indexing (email available below). General contact details of provider: http://www.nature.com .

    Please note that corrections may take a couple of weeks to filter through the various RePEc services.

    IDEAS is a RePEc service. RePEc uses bibliographic data supplied by the respective publishers.